| 11434268 |
Vascular endothelial growth factor antagonists |
Donald P. Bottaro |
2022-09-06 |
| 10722531 |
OPRT expression and cancer treatment outcome |
Todd Hembrough, Dongyao YAN |
2020-07-28 |
| 10722509 |
Predicting optimal chemotherapy for CRC |
Todd Hembrough |
2020-07-28 |
| 10725045 |
Quantifying MGMT protein for optimal cancer therapy of glioblastoma |
Todd Hembrough, Dongyao YAN |
2020-07-28 |
| 10617717 |
Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy |
Todd Hembrough, Jean-Charles Soria |
2020-04-14 |
| 10585099 |
SRM/MRM assays for cancer |
Todd Hembrough, Sarit SCHWARTZ, Kerry SCOTT |
2020-03-10 |
| 10537576 |
Methods for treating Her2-positive breast cancer |
Adele Blackler, Todd Hembrough, Paolo Nuciforo |
2020-01-21 |
| 10288616 |
Quantifying met protein for cancer treatment |
Daniel CATENACCI, Todd Hembrough, Wei-Li Liao |
2019-05-14 |
| 10035833 |
Vascular endothelial growth factor antagonists and methods of making |
Donald P. Bottaro |
2018-07-31 |
| 9746477 |
Quantifying FR-α and GART proteins for optimal cancer therapy |
Todd Hembrough, Eunkyung An, Manish MONGA |
2017-08-29 |
| 9550818 |
Methods for use of vascular endothelial growth factor antagonists |
Donald P. Bottaro |
2017-01-24 |